title: New options for untreatable coronary artery disease: angiogenesis and laser revascularization.
abstract: Some patients with severe symptomatic coronary artery disease despite maximal medical therapy are not eligible for bypass surgery or percutaneous coronary intervention, but may be eligible for two newer therapies: therapeutic angiogenesis with growth factors and transmyocardial laser revascularization.
authors.affiliation: Department of Cardiology, Cleveland Clinic, USA. mukherd@ccf.org
authors.forename: D
authors.initials: D
authors.lastname: Mukherjee
authors.forename: S G
authors.initials: SG
authors.lastname: Ellis
mesh_terms: D000465:Algorithms; D000787:Angina Pectoris / Q000145:classification; D003327:Coronary Disease / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D016228:Endothelial Growth Factors / Q000627:therapeutic use*; D005346:Fibroblast Growth Factors / Q000627:therapeutic use*; D006801:Humans; D053685:Laser Therapy; D008222:Lymphokines / Q000627:therapeutic use*; D017202:Myocardial Ischemia / Q000628:therapy; D009204:Myocardial Revascularization; D020033:Protein Isoforms / Q000627:therapeutic use*; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
chemical_list: D016228:Endothelial Growth Factors; D008222:Lymphokines; D020033:Protein Isoforms; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D005346:Fibroblast Growth Factors